Applied DNA Sciences Inc (APDN)
0.155
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.1594
0.00 (0.00%)
Pre-Market: 09:18
Applied DNA Sciences Gross Profit Margin (Quarterly): 30.75% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 30.75% |
| March 31, 2024 | 31.80% |
| December 31, 2023 | 25.93% |
| September 30, 2023 | 10.13% |
| June 30, 2023 | 43.51% |
| March 31, 2023 | 41.01% |
| December 31, 2022 | 45.18% |
| September 30, 2022 | 11.71% |
| June 30, 2022 | 24.19% |
| March 31, 2022 | 40.48% |
| December 31, 2021 | 26.63% |
| September 30, 2021 | 35.11% |
| June 30, 2021 | 34.36% |
| March 31, 2021 | 64.79% |
| December 31, 2020 | 68.09% |
| September 30, 2020 | 16.75% |
| June 30, 2020 | 64.13% |
| March 31, 2020 | 67.49% |
| December 31, 2019 | 63.37% |
| September 30, 2019 | 80.86% |
| June 30, 2019 | 86.81% |
| March 31, 2019 | 82.90% |
| December 31, 2018 | 82.64% |
| September 30, 2018 | 79.03% |
| June 30, 2018 | 75.15% |
| Date | Value |
|---|---|
| March 31, 2018 | 64.35% |
| December 31, 2017 | 48.83% |
| September 30, 2017 | 76.20% |
| June 30, 2017 | 87.07% |
| March 31, 2017 | 67.15% |
| December 31, 2016 | 69.56% |
| September 30, 2016 | 73.41% |
| June 30, 2016 | 72.34% |
| March 31, 2016 | 55.74% |
| December 31, 2015 | 86.08% |
| September 30, 2015 | 93.59% |
| June 30, 2015 | 94.31% |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
10.13%
Minimum
Sep 2023
68.09%
Maximum
Dec 2020
39.23%
Average
35.11%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 40.24% |
| XWELL Inc | 24.38% |
| ProPhase Labs Inc | -5.24% |
| Veracyte Inc | 68.19% |
| OncoCyte Corp | 43.48% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -129.0% |
| Return on Assets | -55.87% |
| Return on Invested Capital | -129.0% |
| Operating Margin (Quarterly) | -419.6% |
| Return on Net Operating Assets | -152.4% |